跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42,205 条关于
“fragile-X mental retardation protein”
全部
42,205
临床试验
31,950
药物
2,035
机构
422
资讯
7,798
2年前
Opna Bio Initiates Phase I Trial of OPN-6602 for Multiple Myeloma
2年前
Two Major Breakthroughs in Fragile X Syndrome Treatments
去年
Mirum Pharmaceuticals to Launch Phase 2 Trial of MRM-3379 for Fragile X Syndrome
去年
Zatolmilast Shows Promise in Treating Fragile X Syndrome
去年
QurAlis Secures Exclusive License for Novel RNA-Targeted Therapy in Fragile X Syndrome
2年前
FDA Grants Orphan Drug Status to Spinogenix's SPG601 for Fragile X Syndrome
9个月前
Mirum Pharmaceuticals Initiates Phase II Trial of MRM-3379 for Fragile X Syndrome
去年
Fragile X Syndrome Market Set for $83.2M Growth with Novel Therapeutic Approaches
11个月前
Harmony Biosciences' ZYN002 Phase 3 Trial Fails to Meet Primary Endpoint in Fragile X Syndrome
去年
EMA Grants Orphan Drug Designations for Fragile X Syndrome and Radiation-Induced Maculopathy Treatments
第 1 页，共 780 页
上一页
下一页
